These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32918128)

  • 1. Prediction of breast cancer-related outcomes with the Edmonton Symptom Assessment Scale: A literature review.
    Milton L; Behroozian T; Coburn N; Trudeau M; Razvi Y; McKenzie E; Karam I; Lam H; Chow E
    Support Care Cancer; 2021 Feb; 29(2):595-603. PubMed ID: 32918128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of automated screening with Edmonton Symptom Assessment System (ESAS) on health-related quality of life, supportive care needs, and patient satisfaction with care in 268 ambulatory cancer patients.
    Diplock BD; McGarragle KMC; Mueller WA; Haddad S; Ehrlich R; Yoon DA; Cao X; Al-Allaq Y; Karanicolas P; Fitch MI; Myers J; Mitchell AJ; Ellis JWM
    Support Care Cancer; 2019 Jan; 27(1):209-218. PubMed ID: 29931490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptoms Predictive of Overall Quality of Life Using the Edmonton Symptom Assessment Scale in Breast Cancer Patients Receiving Radiotherapy.
    Chow S; Wan BA; Pidduck W; Zhang L; DeAngelis C; Chan S; Yee C; Drost L; Leung E; Sousa P; Lewis D; Lam H; Chow R; Lock M; Chow E
    Clin Breast Cancer; 2019 Dec; 19(6):405-410. PubMed ID: 31182402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-reported symptoms before palliative radiotherapy predict survival differences.
    Nieder C; Kämpe TA; Pawinski A; Dalhaug A
    Strahlenther Onkol; 2018 Jun; 194(6):533-538. PubMed ID: 29344766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-screening of patient-reported symptoms using the Edmonton Symptom Assessment System in outpatient palliative cancer care.
    Lee G; Kim HS; Lee SW; Park YR; Kim EH; Lee B; Hu YJ; Kim KA; Kim D; Cho HY; Kang B; Choi HJ
    Eur J Cancer Care (Engl); 2020 Nov; 29(6):e13305. PubMed ID: 33016473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Edmonton symptom assessment scale: Italian validation in two palliative care settings.
    Moro C; Brunelli C; Miccinesi G; Fallai M; Morino P; Piazza M; Labianca R; Ripamonti C
    Support Care Cancer; 2006 Jan; 14(1):30-7. PubMed ID: 15937688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a French Version of the Edmonton Symptom Assessment System-Revised: A Pilot Study of Palliative Care Patients' Perspectives.
    Nekolaichuk C; Huot A; Gratton V; Bush SH; Tarumi Y; Watanabe SM
    J Palliat Med; 2017 Sep; 20(9):966-976. PubMed ID: 28448236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-Reported Symptoms Improve Performance of Risk Prediction Models for Emergency Department Visits Among Patients With Cancer: A Population-Wide Study in Ontario Using Administrative Data.
    Sutradhar R; Rostami M; Barbera L
    J Pain Symptom Manage; 2019 Nov; 58(5):745-755. PubMed ID: 31319103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of a Symptom Assessment Tool in Shaping Patient-Physician Communication in Palliative Care.
    Brooks JV; Poague C; Formagini T; Sinclair CT; Nelson-Brantley HV
    J Pain Symptom Manage; 2020 Jan; 59(1):30-38. PubMed ID: 31494177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Edmonton symptom assessment scale as a prognosticative indicator in patients with advanced cancer.
    Zeng L; Zhang L; Culleton S; Jon F; Holden L; Kwong J; Khan L; Tsao M; Danjoux C; Sahgal A; Barnes E; Chow E
    J Palliat Med; 2011 Mar; 14(3):337-42. PubMed ID: 21254813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptom Burden Associated With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy.
    Milton L; Behroozian T; Li N; Zhang L; Lou J; Karam I; Wronski M; McKenzie E; Mawdsley G; Razvi Y; Chow E; Ruschin M
    Clin Breast Cancer; 2022 Apr; 22(3):e387-e398. PubMed ID: 34810145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Edmonton Symptom Assessment System: Ascites Modification.
    Mori M; Morita T; Yokomichi N; Nitto A; Takahashi N; Miyamoto S; Nishie H; Matsuoka J; Sakurai H; Ishihara T; Tarumi Y; Ogawa A
    J Pain Symptom Manage; 2018 Jun; 55(6):1557-1563. PubMed ID: 29581035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined cancer patient-reported symptom and health utility tool for routine clinical implementation: a real-world comparison of the ESAS and EQ-5D in multiple cancer sites.
    Moskovitz M; Jao K; Su J; Brown MC; Naik H; Eng L; Wang T; Kuo J; Leung Y; Xu W; Mittmann N; Moody L; Barbera L; Devins G; Li M; Howell D; Liu G
    Curr Oncol; 2019 Dec; 26(6):e733-e741. PubMed ID: 31896943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Accuracy of the Edmonton Symptom Assessment System for the Assessment of Depression in Patients With Cancer: A Systematic Review and Meta-Analysis.
    Boonyathee S; Nagaviroj K; Anothaisintawee T
    Am J Hosp Palliat Care; 2018 Apr; 35(4):731-739. PubMed ID: 29186983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Edmonton Symptom Assessment System: A narrative review of a standardized symptom assessment tool in head and neck oncology.
    Noel CW; Forner D; Chepeha DB; Baran E; Chan KKW; Parmar A; Husain Z; Karam I; Hallet J; Coburn NG; Eskander A
    Oral Oncol; 2021 Dec; 123():105595. PubMed ID: 34775181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Baseline Edmonton Symptom Assessment Scale Scores on Treatment and Survival in Patients With Advanced Non-small-cell Lung Cancer.
    McGee SF; Zhang T; Jonker H; Laurie SA; Goss G; Nicholas G; Albaimani K; Wheatley-Price P
    Clin Lung Cancer; 2018 Jan; 19(1):e91-e99. PubMed ID: 28666762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Italian version of the Edmonton Symptom Assessment System (ESAS)-Total Care (TC): development and psychometric validation in patients undergoing cancer treatment or follow-up.
    Ripamonti C; Leporati R; De Feo G; Di Pede P; Toffolatti L; Guglielmo M; La Carpia D; Miccinesi G; Chiesi F
    Support Care Cancer; 2022 Mar; 30(3):1923-1933. PubMed ID: 34623487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Edmonton Symptom Assessment Scale Time Duration of Self-Completion Versus Assisted Completion in Patients with Advanced Cancer: A Randomized Comparison.
    Wong A; Tayjasanant S; Rodriguez-Nunez A; Park M; Liu D; Zapata KP; Allo J; Frisbee-Hume S; Williams J; Bruera E
    Oncologist; 2021 Feb; 26(2):165-171. PubMed ID: 33252169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcultural Validation of the French Version of the Modified Edmonton Symptom Assessment Scale: The ESAS12-F.
    Tricou C; Ruer M; Nekolaichuk C; Sigurdardottir K; Perceau-Chambard E; Bruera E; Filbet M
    J Palliat Med; 2019 Dec; 22(12):1553-1560. PubMed ID: 31287375
    [No Abstract]   [Full Text] [Related]  

  • 20. Does routine symptom screening with ESAS decrease ED visits in breast cancer patients undergoing adjuvant chemotherapy?
    Barbera L; Sutradhar R; Howell D; Sussman J; Seow H; Dudgeon D; Atzema C; Earle C; Husain A; Liu Y; Krzyzanowska MK
    Support Care Cancer; 2015 Oct; 23(10):3025-32. PubMed ID: 25711657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.